Toothfairy Raises £7.3M to Bring Digital-First Dentistry to Employers, Insurers, and Millions More Patients
August 4, 2025
Toothfairy, the London-based digital dentistry platform, raised £7.3 million ($10 million) in an oversubscribed funding round in August 2025, led by LBO France with participation from CRB Health, Portfolio Ventures, Slingshot, and existing investors. The capital will enable Toothfairy to expand into new treatment verticals, scale its employer and insurer partnerships, and continue developing the digital and AI infrastructure underpinning its platform.
Dental care access in the UK is broken. NHS dental capacity has declined sharply in recent years, with waiting lists growing and millions unable to access timely routine care. The British Dental Association has documented cases of patients attempting DIY dentistry as a consequence of access failure, and surveys consistently show that large numbers of people delay treatment until pain forces them to seek care, by which point conditions have become significantly more costly and complex to manage. For those with dental coverage through insurance or employer benefits, the experience of actually accessing care is often equally frustrating: coverage exists on paper, but the practical pathway to treatment — finding an available NHS dentist, navigating private fees, understanding what’s covered — remains opaque and cumbersome.
Toothfairy was founded in 2018 by Dr Deepak Aulak and Dr Kian Dhinsa, both King’s College London dentistry graduates, to bridge these gaps through technology. The platform connects patients with licensed dentists through an app, enabling on-demand virtual consultations for a range of common conditions, AI-assisted diagnostics, prescription management, and clinical escalation when in-person treatment is needed. For orthodontics, Toothfairy provides clear aligner therapy supervised remotely by registered dentists at significantly lower cost than clinic-based alternatives, using 3D scanning, AI treatment planning, and remote monitoring to enable clinical oversight without requiring frequent in-person visits. The platform holds CQC and GPhC regulatory approvals and has served a significant patient base across the UK.
The £7.3 million round marks a strategic evolution in Toothfairy’s commercial model. The company is expanding from primarily direct-to-consumer to a B2B2C model serving employers and insurers, who represent a large and underserved channel for dental care delivery. Employers are increasingly expected to provide meaningful health benefits that address dental care — one of the most common healthcare needs for working-age adults — but the existing options for employer dental benefits are either expensive insurance products or basic discount schemes. Toothfairy’s employer offering gives companies a genuinely accessible, technology-enabled dental care pathway that can be integrated into benefits packages, with the clinical quality and patient experience that alternatives have failed to deliver. A partnership with Canada Life, covering 2.8 million workers, demonstrated the commercial viability of this channel.
LBO France’s lead investment reflects a thesis gaining traction across Europe’s healthcare investment community: that consumer digital health platforms can create significant value by transitioning from D2C models, which are expensive to scale, toward B2B healthcare service delivery, where per-unit economics are stronger and the sales cycle, though longer, creates durable, institutional relationships. For Toothfairy, the employer and insurer channel also creates a virtuous dynamic: institutional partners provide volume and credibility, while the underlying consumer platform continues to serve the large proportion of patients who will always prefer to access care directly.
Sources
Thank you to our Patrons & Partners:
